Table 3.
Placebo (n = 55) | Anakinra (n = 84) | P-value | |
---|---|---|---|
Serious infections (%) | 7 (13) | 11 (13) | 1.0 |
Injection site reaction (%) | 3 (5) | 19 (23) | 0.016 |
Injection site reaction leading to discontinuation (%) | 1 (2) | 6 (7) | 0.160 |
Death (%) | 2 (4) | 0 (0) | 0.155 |